MAL formulation (D&A Pharma)

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMAL formulation (D&A Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor antagonistsKappa opioid receptor agonists
TargetsMu opioid receptorKappa opioid receptor
Therapy Area/IndicationsOpioid-Related DisordersPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesD&A Pharma
China Registration ClassN/A

Develop Information

Active CompaniesD&A Pharma
Inactive CompaniesN/A
Active IndicationsOpioid-Related DisordersPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A